Sanz-Mengibar Jose Manuel, Menendez-Pardiñas Monica, Santonja-Medina Fernando
Balancephysio, London, United Kingdom.
Faculty of Medicine, University of Murcia, Spain.
Ideggyogy Sz. 2021 Sep 30;74(9-10):329-336. doi: 10.18071/isz.74.0329.
Vojta therapy has been reported as clinically beneficial for strength, movement and gross motor activities in individual cases and is being included within the second of three levels of evidence in interventions for cerebral palsy. The goal of this study is to understand the effect of Vojta therapy on the gross motor function.
Our clinical trial followed a one group, pre-post design to quantify rates of changes in GMFM-88 after a two-months period undergoing Vojta therapy.
A total of 16 patients were recruited. Post-intervention acceleration rates of GMFM-88-items acquisition (0.005; p<0.001) and Locomotor Stages (1.063; p<0.0001) increased significatively following Vojta the-rapy intervention.
In this study, Vojta therapy has shown to accelerate the acquisition of GMFM-88-items and Loco-motor Stages in children with cerebral palsy younger than 18 months. Because functional training was not utilised, and other non-Vojta therapy intervention did not influence the outcome, Vojta therapy seems to activate the postural control required to achieve uncompleted GMFM-88-items.
据报道,vojta疗法对个别病例的力量、运动和粗大运动活动具有临床益处,并且已被纳入脑瘫干预三级证据中的二级。本研究的目的是了解vojta疗法对粗大运动功能的影响。
我们的临床试验采用单组前后设计,以量化在接受两个月vojta疗法后,粗大运动功能测量量表(GMFM-88)的变化率。
共招募了16名患者。接受vojta疗法干预后,GMFM-88项目获得(0.005;p<0.001)和运动阶段(1.063;p<0.0001)的干预后加速率显著增加。
在本研究中,vojta疗法已显示出可加速18个月以下脑瘫儿童GMFM-88项目和运动阶段的获得。由于未采用功能训练,且其他非vojta疗法干预未影响结果,vojta疗法似乎激活了实现未完成的GMFM-88项目所需的姿势控制。